GE HealthCare Technologies Inc. Common Stock

GEHC trades at a 13.3 P/E with an RSI of 29.4—deep into oversold territory and substantially cheaper than the broader tech sector's typical 18-22 multiple. The $33.4B market cap belies genuine medical imaging demand tailwinds, yet the stock sits well below its 52-week high, suggesting either sector headwinds or unwarranted pessimism. At these valuation levels with extreme oversold readings, the risk-reward skews favorably for mean-reversion, though oversold conditions can persist amid deteriorating fundamentals. The absence of short float data limits insight into squeeze potential, leaving the setup ambiguous: either a capitulation-driven buying opportunity in a structurally sound business or a justified discount signaling deeper problems.